[P4–014]: THE COALITION AGAINST MAJOR DISEASES: TOWARD U.S. FDA QUALIFICATION OF HIPPOCAMPAL VOLUME AS A BIOMARKER FOR ENRICHMENT IN CLINICAL TRIALS FOR PRE‐DEMENTIA STAGES OF ALZHEIMER'S DISEASE. (1st July 2017) - Conrado, Daniela J.; Romero, Klaus; Corrigan, Brian; Ito, Kaori; Nicholas, Timothy; Chen, Danny; Samtani, Mahesh N.; Stone, Julie; Sinha, Vikram; Willis, Brian A.; Kern, Volker D.; Hill, Derek L.; et al.